A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Update Il y a 4 ans
Reference: NCT01130493

Woman and Man

Extract

This is a study to compare the efficacy of IPX066 and CLE in subjects with advanced Parkinson's disease.


Inclusion criteria

  • Parkinson's disease


Links